Treatment of High-Risk Neuroblastoma
Julie Krystal, Jennifer H. Foster
Abstract
High-risk neuroblastoma is a highly aggressive solid tumor that most commonly presents in early childhood. Advances in treatment through decades of clinical trials and research have led to improved outcomes. This review provides an overview of the current state of treatment for high-risk neuroblastoma.
Topics & Concepts
NeuroblastomaMedicineIntensive care medicineSolid tumorClinical trialOncologyInternal medicineCancerBiologyGeneticsCell cultureNeuroblastoma Research and Treatments